The trademark application was filed by GlaxoSmithKline Consumer Healthcare (UK) IP Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on April 25, 2005, and it was registered by office on November 18, 2005 without any oppositions.
The application was filed in English (French was selected as the second language).
The renewal of the trademark was recorded by the office on January 29, 2014.
A transfer of the trademark registration was recorded on February 14, 2008. Change of name and address of the trademark registration was recorded on March 20, 2013. Change of name and professional address of the trademark registration was recorded on August 28, 2013. Appointment and Replacement of representative of the trademark registration was recorded on September 2, 2013. A transfer of the trademark registration was recorded on April 29, 2016. Deletion of the representative of the trademark registration was recorded on January 7, 2021. Appointment and Replacement of representative of the trademark registration was recorded on March 8, 2021.